236
Views
7
CrossRef citations to date
0
Altmetric
Research Article

In vitro and in vivo evaluation of 99mTc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors

, , &
Pages 761-769 | Received 11 Oct 2010, Accepted 01 Feb 2011, Published online: 22 Mar 2011

References

  • Antony AC. (1996). Folate Receptors. Annu Rev Nutr, 16, 501–521.
  • Cho BK, Edward JR, Todd A, Patrick Kranz DM. (1997). Single chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells. Bioconj Chem, 8, 338–346.
  • Duimstra JA, Femia FJ, Meade TJ. (2005). A gadolinium chelate for detection of â-glucuronidase: A self-immolative approach. J Am Chem Soc, 127, 12847–12855.
  • Gabizon A, Shmeeda H, Horowitz AT, Zalipsky S. (2004). Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid–PEG conjugates. Adv Drug Del Rev, 56, 1177–1192.
  • Guo W, Hinkle GH, Lee RJ. (1999). 99mTc-HYNIC-folate a novel receptor-based targeted radiopharmaceutical for tumor imaging. J Nucl Med, 40, 1563–1569.
  • Hilgenbrink AR, Low PS. (2005). Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci, 94, 2135–2146.
  • Ilgan S, Yang DJ, Higuchi T, Zareneyrizi F, Bayhan H, Yu D, Kim EE, Podoloff DA. (1998). 99mTc-ethylenedicysteine-folate: a new tumor-imaging agent, Synthesis, labeling and evaluation in animals. Cancer Biother Radiopharm, 13, 427–435.
  • Leamon CP, Reddy JA, Vlahov IR, Vetzel M, Parker N, Nicoson JS, Xu LC, Westrick E. (2005). Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic. Bioconjug Chem, 16, 803–811.
  • Leamon CP, Reddy JA, Vlahov IR, Westrick E, Dawson A, Dorton R, Vetzel M, Santhapuram HK, Wang Y. (2007). Preclinical antitumor activity of a novel folate-targeted dual drug conjugate. Mol Pharm, 4, 659–667.
  • Leamon CP, Reddy JA. (2004). Folate-targeted chemotherapy. Adv Drug Deliv Rev, 56, 1127–1141.
  • Lee RJ, Low PS. (1994). Delivery of liposomes into cultured KB cells via folate receptor- mediated endocytosis. J Biol Chem, 269, 3198–3204.
  • Luhrs CA, Slomiany BL. (1989). A human membrane-associated folate binding protein is anchored by a glycosylphosphatidylinositol tail. J Biol Chem, 264, 21446–21449.
  • Mathias CJ, Hubers D, Low PS. (2000). Synthesis of [99mTc] DTPA-Folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. Bioconj Chem, 11, 253–257.
  • Mathias CJ, Wang S, Lee RJ, Low PS, Waters DJ, Green MA. (1999). Receptor mediated targeting of 67Gallium-Deferoxamine-folate to folate receptor positive Human KB tumor xenographts. Nucl Med Biol, 26, 23–25.
  • Min L, Wen X, Xu LJ, Zhong GR, Chen SL, Lu WY. (2005). Synthesis and biological evaluation of diethylenetriamine pentaacetic acid-polyethylene glycol-folate: A new folate-derived, 99mTc-based radiopharmaceutical. Bioconj Chem, 16, 1126–1132.
  • Mishra A, Pfeuffer J, Mishra R, Engelmann J, Mishra AK, Ugurbil K, Logothetis NK. (2006). A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging. Bioconjug Chem, 17, 773–780.
  • Mishra AK, Chatal JF. (2001). Synthesis of macrocyclic bifunctional chelating agents: 1,4,7-tris(carboxymethyl)-10-(2-aminoethyl)- 1,4,7,10-tetraazacyclododecane and 1,4,8-tris(carboxymethyl)-11-(2-aminoethyl)-1,4,8,11-tetraazacyclotetradecane. New J Chem, 25, 336–339.
  • Müller C, Schubiger PA, Schibli R. (2006). In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer. Eur J Nucl Med Mol Imaging, 33, 1162–1170.
  • Ni S, Stephenson SM, Lee RJ. (2002). Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. Anticancer Res, 22, 2131–2135.
  • Panwar P, Srivastava V, Tandon V, Mishra P, Chuttani K, Sharma RK, Chandra R, Mishra AK. (2004). (99m)Tc-Tetraethylenepentaminefolate-A new (99m)Tc-based folate derivative for the detection of folate receptor positive tumors: Synthesis and biological evaluation. Cancer Biol Ther, 3, 995–1001.
  • Reddy JA, Low PS. (1998). Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Ther Drug Carrier Syst, 15, 587–627.
  • Siegel BA, Dehdashti F, Mutch DG, Podoloff DA, Wendt R, Sutton GP, Burt RW, Ellis PR, Mathias CJ, Green MA, Gershenson DM. (2003). Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. J Nucl Med, 44, 700–707.
  • Subramanian R, Meares CF. (1990). Bifunctional chelating agents for radiometal-labeled monoclonal antibodies. Cancer Treat Res, 51, 183–199.
  • Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, Boiocchi M. (1997). Overexpression of folate binding protein in ovarian cancers. Int J Cancer, 74, 193–198.
  • Turek JJ, Leamon CP, Low PS. (1993). Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. J Cell Sci, 106 (Pt 1), 423–430.
  • Wang S, Low PS. (1998). Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release, 53, 39–48.
  • Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR, Kamen BA. (1992). Distribution of the folate receptor (GP38) in normal and malignant cell lines and tissues. Cancer Res, 52, 3396–3401.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.